Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
出版年份 2022 全文链接
标题
Immunogenicity and efficacy of COVID-19 vaccines in people living with HIV: a systematic review and meta-analysis
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume 124, Issue -, Pages 212-223
出版商
Elsevier BV
发表日期
2022-10-12
DOI
10.1016/j.ijid.2022.10.005
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV
- (2022) Manuel González de Aledo et al. AIDS
- Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China
- (2022) Xiaojie Huang et al. Viruses-Basel
- Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
- (2022) Ane Ogbe et al. JCI Insight
- Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
- (2022) Andrea Antinori et al. CLINICAL INFECTIOUS DISEASES
- The immunology and immunopathology of COVID-19
- (2022) Miriam Merad et al. SCIENCE
- Characterization of Serum and Mucosal SARS-CoV-2-Antibodies in HIV-1-Infected Subjects after BNT162b2 mRNA Vaccination or SARS-CoV-2 Infection
- (2022) Katja G. Schmidt et al. Viruses-Basel
- Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
- (2022) Shabir A Madhi et al. Lancet HIV
- Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
- (2022) Lucas C Netto et al. Lancet HIV
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
- (2022) Zabrina L. Brumme et al. npj Vaccines
- COVID-19 Vaccine: Between Myth and Truth
- (2022) Pier Paolo Piccaluga et al. Vaccines
- People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
- (2022) Hope R Lapointe et al. JOURNAL OF INFECTIOUS DISEASES
- Immune response and safety to inactivated COVID-19 vaccine: a comparison between people living with HIV and HIV-naive individuals
- (2022) Shi Zou et al. AIDS Research and Therapy
- IgG Antibody Responses and Immune Persistence of Two Doses of BBIBP-CorV Vaccine or CoronaVac Vaccine in People Living with HIV (PLWH) in Shenzhen, China
- (2022) Guang Zeng et al. Vaccines
- Necessity of 2 Doses of the Pfizer and Moderna COVID-19 Vaccines
- (2021) Edward H. Livingston JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Correlates of Neutralization Against SARS-CoV-2 Variants of Concern by Early Pandemic Sera
- (2021) Samuel J. Vidal et al. JOURNAL OF VIROLOGY
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
- (2021) Nicole Doria-Rose et al. NEW ENGLAND JOURNAL OF MEDICINE
- Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
- (2021) Paddy Ssentongo et al. Scientific Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Quantitative SARS-CoV-2 anti-spike responses to Pfizer–BioNTech and Oxford–AstraZeneca vaccines by previous infection status
- (2021) David W. Eyre et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity
- (2021) David Hagin et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
- (2021) Ottavia M. Delmonte et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Evidence for antibody as a protective correlate for COVID-19 vaccines
- (2021) Kristen A. Earle et al. VACCINE
- Covid-19: UK will offer third vaccine dose to severely immunosuppressed people
- (2021) Jacqui Wise BMJ-British Medical Journal
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
- (2021) Shabir A Madhi et al. Lancet HIV
- Safety and Efficacy of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Different Vaccines at Phase 3
- (2021) Yu-Jing Fan et al. Vaccines
- Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV
- (2021) Khadija Khan et al. CLINICAL INFECTIOUS DISEASES
- Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV
- (2021) Jessica J. Tuan et al. HIV MEDICINE
- Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
- (2021) Nils Jedicke et al. HIV MEDICINE
- Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
- (2021) Zhengchao Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Immunogenicity of Conjugated and Polysaccharide Pneumococcal Vaccines Administered During Pregnancy or Postpartum to Women With HIV
- (2021) Geraldo Duarte et al. JOURNAL OF INFECTIOUS DISEASES
- Humoral response to two doses of BNT162b2 vaccination in people with HIV
- (2021) Line Dam Heftdal et al. JOURNAL OF INTERNAL MEDICINE
- Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
- (2021) Noam Barda et al. LANCET
- China’s COVID vaccines have been crucial — now immunity is waning
- (2021) Smriti Mallapaty NATURE
- SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
- (2021) Ramon Roozendaal et al. Nature Communications
- Humoral and Cellular Response Following Vaccination With the BNT162b2 mRNA COVID-19 Vaccine in Patients Affected by Primary Immunodeficiencies
- (2021) Donato Amodio et al. Frontiers in Immunology
- Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis
- (2021) Yakun Tian et al. Frontiers in Immunology
- Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
- (2021) Peter Bergman et al. EBioMedicine
- Immunogenicity and safety of different dosing schedules of trivalent inactivated influenza vaccine in pregnant women with HIV: a randomised controlled trial
- (2020) Marta C Nunes et al. Lancet HIV
- Severe Covid-19
- (2020) David A. Berlin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of immune response of double dose of hepatitis B vaccination in HIV-infected patients
- (2020) Jung-Hwan Lee et al. VACCINE
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
- (2020) Kizzmekia S. Corbett et al. NEW ENGLAND JOURNAL OF MEDICINE
- COVID-19-neutralizing antibodies predict disease severity and survival
- (2020) Wilfredo F. Garcia-Beltran et al. CELL
- Immunogenicity And Safety Of The Nine-Valent Human Papillomavirus Vaccine In Solid Organ Transplant Recipients And Hiv-Infected Adults
- (2020) Lise Boey et al. CLINICAL INFECTIOUS DISEASES
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA vaccines against COVID-19: Perspectives and challenges
- (2020) Marcelle Moura Silveira et al. LIFE SCIENCES
- RNA respiratory viral infections in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice
- (2019) Oriol Manuel et al. CLINICAL TRANSPLANTATION
- mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
- (2019) Robert A. Feldman et al. VACCINE
- iHIVARNA phase IIa, a randomized, placebo-controlled, double-blinded trial to evaluate the safety and immunogenicity of iHIVARNA-01 in chronically HIV-infected patients under stable combined antiretroviral therapy
- (2019) Wesley de Jong et al. Trials
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Impact of aging and HIV infection on serologic response to seasonal influenza vaccination
- (2018) Suresh Pallikkuth et al. AIDS
- Immunogenicity of AGS-004 Dendritic Cell Therapy in Patients Treated During Acute HIV Infection
- (2018) Cynthia L. Gay et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Influenza vaccination for HIV-positive people: Systematic review and network meta-analysis
- (2018) Wei Zhang et al. VACCINE
- Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial
- (2017) Martin Alberer et al. LANCET
- Influenza vaccination in HIV-infected individuals: Systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety
- (2014) Cornelius Remschmidt et al. VACCINE
- Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1
- (2012) Jennifer A Whitaker et al. LANCET INFECTIOUS DISEASES
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
- (2008) Gordon H Guyatt et al. BMJ-British Medical Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started